---
category: listing
circular_id: 47c65e0238f38e01
date: '2025-12-29'
description: 27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed
  on BSE with effect from December 30, 2025, issued on preferential basis pursuant
  to conversion of warrants.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={574F2A3B-FBA4-4A08-B4C9-AA036082E8C7}&noticeno=20251229-18&dt=12/29/2025&icount=18&totcount=45&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of preferential shares for a small-cap company. Limited
  market-wide impact, relevant primarily to specific shareholders and the company.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251229-18&attachedId=
processing:
  attempts: 1
  content_hash: f980c563d8bb9c62
  processed_at: '2025-12-29T18:47:38.108049'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-29T12:34:19+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={574F2A3B-FBA4-4A08-B4C9-AA036082E8C7}&noticeno=20251229-18&dt=12/29/2025&icount=18&totcount=45&flag=0
severity: low
source: bse
stocks:
- VENMAX
tags:
- listing
- equity-shares
- preferential-allotment
- warrant-conversion
- lock-in
title: Listing of New Securities of Venmax Drugs And Pharmaceuticals Ltd
---

## Summary

BSE has announced the listing of 27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd (Scrip Code: 531015) effective December 30, 2025. These shares were issued to non-promoters on a preferential basis pursuant to conversion of warrants at Rs. 20/- per share (face value Rs. 10/- with premium of Rs. 10/-). The shares rank pari-passu with existing equity shares and are subject to lock-in until July 13, 2026.

## Key Points

- Total shares listed: 27,69,000 equity shares of Rs. 10/- each
- Issued at Rs. 20/- per share (Rs. 10/- face value + Rs. 10/- premium)
- Allotted to non-promoters on preferential basis pursuant to warrant conversion
- Trading commences: December 30, 2025
- ISIN: INE154G01022
- Scrip Code: 531015
- Shares rank pari-passu with existing equity shares
- All shares under lock-in until July 13, 2026

## Regulatory Changes

No regulatory changes announced. This is a standard listing notification for new securities.

## Compliance Requirements

Trading members are informed to note the listing of these new securities for trading purposes. The lock-in restrictions must be observed until the specified date.

## Important Dates

- **August 16, 2025**: First allotment of 20,55,000 shares (Dist. Nos. 5238931-7293930)
- **August 30, 2025**: Second allotment of 3,60,667 shares (Dist. Nos. 7293931-7654597)
- **September 16, 2025**: Third allotment of 3,53,333 shares (Dist. Nos. 7654598-8007930)
- **December 30, 2025**: Effective date for trading
- **July 13, 2026**: Lock-in period expires

## Impact Assessment

This is a routine corporate action with minimal market-wide impact. The listing adds 27,69,000 shares to the tradable securities of Venmax Drugs And Pharmaceuticals Ltd, though all shares remain locked-in until July 2026. The preferential allotment to non-promoters indicates capital raising activity. Impact is limited to the company's shareholders and potential investors in this specific scrip.